Centoreze tablets.

Each film-coated tablet contains 20 mg of extract (as dry extract) from Pelargonium root

(Pelargonium sidoides DC and/or Pelargonium reniforme Curt. (4-25:1).

Extraction solvent: Ethanol 11% (m/m).

For a full list of excipients see Pharmaceutical particulars tab, list of exipients.

Film-coated tablet.

Red-brown, smooth round, biconvex.

Traditional herbal medicinal product used to relieve the symptoms of upper respiratory tract infections including the common cold, such as sore throat, cough and blocked or runny nose, based on traditional use only.

For oral use only.

Adult, elderly and adolescents above 12 years of age:

Take 1 tablet three times daily (morning, midday, evening).

Tablets should be swallowed whole with a little water. The tablets should not be chewed.

The use in children under 12 years of age is not recommended.

After relief of symptoms, it is recommended to continue treatment for a further 2-3 days in order to prevent a relapse. However, treatment duration should not exceed 10 days.

If the symptoms worsen, or persist after 7 days, a doctor or a qualified health care practitioner should be consulted.

Hypersensitivity to the active substance or to any of the excipients.

Severe hepatic or renal disease.

None reported.

Safety during pregnancy and lactation has not been established. Due to lack of sufficient data, the use during pregnancy and lactation is not recommended.

No studies on the effect on fertility have been performed.

No studies on the effect on the ability to drive and use machines have been performed.

No case of overdose has been reported.

Symptomatic and supportive measures should be taken as appropriate.

Not required as per Article 16c (1) (a) (iii) of Directive 2001/83/EC as amended.

Not required as per Article 16c (1) (a) (iii) of Directive 2001/83/EC as amended.

The extract was negative in an Ames test for mutagenicity.

Tests on reproductive toxicity and carcinogenicity have not been performed.

Extract: Maltodextrin

Tablet core: Cellulose powder, Cellulose microcrystalline, Silica colloidal anhydrous, Magnesium stearate

Film coating: Hypromellose, Macrogol type 6000, Iron oxide yellow E172, Iron oxide red E172, Calcium carbonate, Talc

Not applicable.

5 years.

This product does not require any special storage conditions. Store in the original packaging.

This product is available in packs with 15, 21, 30 or 60 tablets.

The tablets are sealed into PVC/PVDC-aluminium blisters. The blisters are packed into folding cartons. Not all pack sizes may be marketed.

No special requirements.

DePlantis Ltd, Plough Lane, Hereford, HR4 0EL.

THR 53449/0001.

11th January 2022.

3rd November 2022.